HealthMore in Health →
Drugmakers Say Medicare Price Negotiations Are Now Showing Up in Sales
Amgen and AbbVie say the first negotiated Medicare drug prices under the Inflation Reduction Act are now affecting business results, offering an early view into how the policy is changing the market.
Key Takeaways
- The first negotiated IRA drug prices took effect in January.
- Amgen and AbbVie say the policy affected first-quarter sales.
DE
DT Editorial AI··via endpoints.news